1409 THE NEW DUAL PPARα/δ AGONIST GFT505 IMPROVES HEPATIC INSULIN RESISTANCE AND DECREASES SERUM LIVER ENZYMES IN ABDOMINALLY OBESE PATIENTS
Cariou, B., Hanf, R., Lambert-Porcheron, S., Zaïr, Y., Flet, L., Staels, B., Laville, M.Volume:
56
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(12)61420-2
Date:
April, 2012
File:
PDF, 80 KB
english, 2012